1Vardiman JW ,lmbert M , Pierre R,el al. Chronic myelomonocytic leukemia. In:Jaffe ES,Harris NL,Stein H ,et al,editors.World Health Organization classification of tumors : pathology and genetics of turnouts of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2001 : 49-52.
2Pont V,Miquel FJ,Grau TC,et al. Skin involvement in chronic myelomonocytic leukaemia as a predictor of transformation into acute myeloid leukaemia [J].J Eur Acad Dermatol Venerol,2001,15 (3):260-262.
4Orazi A,Germing U.The myelodysplastic/myelopmliferative neoplasms:myeloproliferative diseases with dysplastic features [J]. Leukemia ,2008,22(7) : 1308-1319.
5Laeronique-Gazaille C,Chaury MP,Le Guyader A,et al.A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes:expression of CD56 in CMML [J]. Haematologica, 2007,92(6) : 859-860.
6Sconocchia G,Keyvanfar K ,El Ouriaghli F,et al.Phenotype and function of a CD56 + peripheral blood monocyte [J].Leukemia, 2005,19(1) :69-76.
7Xu Y,McKenna RW, Karandikar NJ.et al.Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis [J].Am J Clin Pathol,2005,124 (5) : 799-806.
8Germing U, Strupp C ,Aivado M,et al.New prognostic parameters "for chronic myelornonocytie leukaemla[J].Blood,2011,100 (8) : 731 - 732.
10Such E, Cervera J, Costa D, et al.Cytogenetic risk stratification in chronic myelomonocytic leukemia [J].Haematologica,2011,96(4): 375-383.
二级参考文献30
1Bennet JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myeloid aplastic syndromes. Br J Haematol, 1982, 51: 189.
2VARDIMAN J W, HARRIS N L,BRUNNING R D. The World Health Organization (WHO) classification of the myeloid neoplasms[J]. Blood, 2002,100 : 2292- 2302.
3MALCOVATI L, GERMING U, KUENDGEN A, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes[J]. J Clin Oncol, 2007,25: 3503 - 3510.
4ONIDA F,KANTARJIAN H M,SMITH T L,et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients[J]. Blood, 2002,99 : 840- 849.
5XU Y,MCKENNA R W, KARANDIKAR N J, et al. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis[J]. Am J Clin Pathol, 2005,124 : 799-806.
6KOJIMA H,BAI A,MUKAI H Y,et al. Chronic myelomonocytic leukemia derived from a possible common progenitor of monocytes and natural killer cells [J]. Leuk Lymphoma, 2000,37 : 617 - 621.
7GERMING U, STRUPP C, AIVADO M, et al. New prognostic parameters for chronic myelomonocytic leukemia[J]. Blood, 2002,100 : 731 - 733.
8KROGER N, ZABELINA T, GUARDIOLA P, et al. Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [J]. Br J Haematol, 2002,118 : 67 - 73.
9Bennett JM,Catovsky D,Daniel MT,et al.Proposals for the clas-sification of the acute leukaemias.French-American-British(FAB)co-operative group.Br J Haematol,1976;33(4):451-458.
10Vardiman JW,Imbert M,Pierre R,et al.Chronic myelomono-cytic leukemia.In:Jaffe ES,Harris NL,Stein H,et al,editors.World Health Organization classification of tumors:pathology andgenetics of tumours of haematopoietic and lymphoid tissues.Lyon:IARC Press,2001:49-52.
